Skip to content
Everbility logo — AI powered tools for allied health professionals

Everbility

AI powered tools for allied health professionals

Australia Australia 4 employees Pre-Seed AI, Health Care

General Information

Company Name Everbility
Location Australia Australia
Employees 4
Industries AI, Health Care
Funding Stage Pre-Seed
Social

BounceWatch is an independent company data service, not affiliated with Everbility. To contact Everbility, visit everbility.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Everbility compare?

A PDF of Everbility and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Everbility soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Everbility

Everbility is an innovative startup offering AI-powered tools tailored for allied health professionals. The company's slogan "AI powered tools for allied health professionals" encapsulates its core focus on providing a documentation assistant that facilitates the synthesis and summarization of client notes, as well as rapid report generation. Everbility operates at the intersection of AI and Health Care, aiming to streamline processes and enhance productivity within the allied health sector. Based in Australia, the company has garnered attention through its recent Pre Seed Round investment on 08 February 2024, with StartMate being the lead investor. With its unique value proposition and targeted solutions for a specific niche, Everbility presents a promising investment opportunity in the evolving landscape of digital health technologies.

Business keywords: AI-powered tools, Occupational Therapy, Documentation assistant, Allied health professionals, Client notes, Report generation, Healthcare documentation, Healthtech startup, Technology for OTs, Medical reports, Efficiency tools, Healthcare innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Pre Seed Round Undisclosed 1
StartMate
08 Feb 2024

Everbility Alternatives & Competitors

View All Alternatives
Everbility vs
Exin Health AI
Exin Health AI United States

ORGenie™....AI Assistant for OR Nurses...Complete perfectly accurate surgical documentation under 60...

10 employees
AI, Health Care
Everbility vs
Medwise AI
Medwise AI United Kingdom

Empowering every healthcare professional to do their best work and provide better care for their pat...

Seed
14 employees
AI, Health Care
Everbility vs
La Ruche Health
La Ruche Health Cote D'ivoire (ivory Coast)

Re-imagining the Patient Experience.

Non Equity Assistance
8 employees
AI, Digital Health

FAQ About Everbility

AI powered tools for allied health professionals
Everbility is headquartered in Australia.
Everbility operates in AI and Health Care. Its work centres on AI-powered tools, Occupational Therapy, Documentation assistant and Allied health professionals.
Everbility has approximately 4 employees.
Everbility has completed 1 funding round. The latest funding stage is Pre-Seed.
Top alternatives and competitors to Everbility include Exin Health AI, Medwise AI, La Ruche Health, Abridge, Ubie. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Everbility and Exin Health AI are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Everbility, https://www.bouncewatch.com/company/everbility, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout